Dipankar Pramanik

Title: **Dipankar Pramanik: Innovator in Oncology Research**

Introduction

Dipankar Pramanik is a distinguished inventor based in Delhi, India. He has made significant strides in the field of oncology through his innovative work on ligand-targeted molecules. With a keen focus on developing advanced therapies for tumor treatment, Pramanik's contributions have the potential to revolutionize cancer treatment.

Latest Patents

Dipankar Pramanik holds a patent titled "Ligand-targeted molecules and methods thereof." This invention encompasses ligand-targeted molecules and ligand drug conjugates (LDCs) that consist of a ligand joined to a functional group, which is attached to a linker that connects to a drug. Notably, this invention includes a platinum coordination complex where the platinum is connected to the linker through monocarboxylato and O→Pt coordinate bonds. The patent also outlines methods for preparing these ligand drug conjugates and their applications in the treatment of tumors.

Career Highlights

Pramanik is currently associated with Invictus Oncology Pvt. Ltd., where he continues to push the boundaries of cancer research. His work is not only innovative but also aims to improve the efficacy of cancer treatments, enhancing patient outcomes and survival rates.

Collaborations

Throughout his career, Dipankar Pramanik has collaborated with notable colleagues, including Shiladitya Sengupta and Sazid Hussain. These collaborations reflect a commitment to advancing research and fostering innovation within the field of oncology.

Conclusion

Dipankar Pramanik exemplifies the spirit of innovation within the medical research community. With his patent on ligand-targeted molecules, he is paving the way for new therapeutic possibilities in tumor treatment. His dedication and collaborative approach underscore the importance of teamwork in driving significant advancements in oncology.